Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hereditary glaucoma is a clinically diverse group of rare eye disorders with genetic predisposition characterized by elevated intraocular pressure (IOP) and glaucomatous changes of the optic nerve head, leading to field defects, visual loss and blindness. Hereditary glaucoma can be sub-classified as primary (congenital glaucoma, juvenile glaucoma) or secondary according to the presence or absence of systemic or other ocular anomalies (iridogoniodysgenesis, Stickler syndrome, Coats syndrome). The clinical presentation is variable and is based on age, severity of glaucoma, presence of ocular abnormalities and development of secondary IOP related abnormalities.
Biomarker and diagnostic research for hereditary glaucoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for hereditary glaucoma.
98 publications have been identified in PubMed for hereditary glaucoma. Kisho has analyzed 53 by research type. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (23%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 21 | 40% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:46 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies
12 |
23% |
Disease patterns and progression | 8 | 15% |
Laboratory research | 5 | 9% |
Clinical study results | 4 | 8% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
New treatment approaches | 1 | 2% |
Kaur K (2026). [PMID: 34662067](https://pubmed.ncbi.nlm.nih.gov/34662067/). *Unknown Journal*. [Case Report / Case Series]
Francia A (2026). [PMID: 41484602](https://pubmed.ncbi.nlm.nih.gov/41484602/). *Neurol Sci*. [Case Report / Case Series]
Fialho ML (2026). [PMID: 42078187](https://pubmed.ncbi.nlm.nih.gov/42078187/). *J Ophthalmol*. [Review / Meta-Analysis]
Ahuja AS (2026). [PMID: 41859471](https://pubmed.ncbi.nlm.nih.gov/41859471/). *Eye Brain*. [Review / Meta-Analysis]
Kaur K (2026). [PMID: 31424860](https://pubmed.ncbi.nlm.nih.gov/31424860/). *Unknown Journal*. [Epidemiology / Natural History]
Pazos M (2026). [PMID: 41686761](https://pubmed.ncbi.nlm.nih.gov/41686761/). *Eur J Ophthalmol*. [Review / Meta-Analysis]
Senthamizh T (2026). [PMID: 38753939](https://pubmed.ncbi.nlm.nih.gov/38753939/). *Unknown Journal*. [Epidemiology / Natural History]
Mikhail MI (2026). [PMID: 29083737](https://pubmed.ncbi.nlm.nih.gov/29083737/). *Unknown Journal*. [Epidemiology / Natural History]
Chapelle AC (2025). [PMID: 40860968](https://pubmed.ncbi.nlm.nih.gov/40860968/). *Front Neurol*. [Review / Meta-Analysis]
Zhou L (2025). [PMID: 39949076](https://pubmed.ncbi.nlm.nih.gov/39949076/). *Eur J Ophthalmol*. [Case Report / Case Series]